[Immunotherapy using the nasal route in bronchial asthma].
A study of 1124 asthmatic patients was performed. Patients belonged to different health centers and outpatients services, as well as to the Hospital Clínico Quirúrgico 10 de Octubre. Besides asthma patients had other allergic associated conditions, such as dermatitis, conjunctivitis, urticaria and rhinitis. Laboratory studies included the following obligatory tests: hemogram, erithro sedimentation, serology urine, stool examination and glucose. Eosinophilia nasal and pharynx exudate. The immunoallergologic study consisted of standard allergic tests using different respiratory inhalant and bacterial extracts, including controls with buffer and histamine. Immunotherapy was initiated using nasal drops during four years including four summers and four winters. Good evolution was observed in 1032 cases (91%), fair in 67 (6%) and no modification without improvement in 25 (2.2%). Conclusions and recommendations are given.
L
L
Robbio Troyano
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000368:Aged; D000485:Allergens / Q000008:administration & dosage*; D001249:Asthma / Q000209:etiology / Q000235:genetics / Q000628:therapy*; D003888:Desensitization, Immunologic; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D000485:Allergens
Inmunoterapia vía nasal en el asma bronquial.